Interestingly, hsa-miR-382-5p was previously reported to exert oncogenic function augmenting the tumorigenic and metastatic potential of BC through diminish the tumor suppressive role of RERG (Ras-related and estrogen-regulated growth inhibitor), a Ras GTPase superfamily member on the oncogenic Ras/ERK pathway22. Here, RERG is linked to breast cancer.